ArticleFrontiers in immunology2024

Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia.

Yu-Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.